This study found the use of injectable antipsychotics varied substantially among state Medicaid programs. African Americans received a disproportionate share in many states.
Related Publications for Comparative Effectiveness Research and Treatment of Serious Mental Illnesses in Medicaid
State and Demographic Variation in Use of Depot Antipsychotics by Medicaid Beneficiaries with SchizophreniaJan 30, 2014
Medication Continuity Among Medicaid Beneficiaries with Schizophrenia and Bipolar DisorderJun 03, 2013
This study examines whether medication continuity among Medicaid beneficiaries with schizophrenia and bipolar disorder was associated with medication utilization management practices (prior authorization, copayment amounts, and refill and pill quantity limits); managed care enrollment; and other state...
Evidence-Based Practices for Medicaid Beneficiaries with Schizophrenia and Bipolar DisorderApr 09, 2012
As part of a project for the U.S. Department of Health and Human Services, Office of the Assistant Secretary for Planning and Evaluation, Office of Disability, Aging, and Long-Term Care Policy, Mathematica produced report examining the use of evidence-based medications, psychosocial services, and physical...